64 / 154
390
classification of Medulloblastoma driving the next generation
clinical trials, Curr Opin Pediatr. 2012 Feb; 24(1): 33–39.
5. Hahn H, Wicking C, Zaphiropoulous PG, et al. Mutations of the
human homolog of Drosophila patched in the nevoid basal
cell carcinoma syndrome.Cell 1996; 85:841–851.
6. Smyth I, Narang MA, Evans T, et al. Isolation and
characterization of human patched 2 (PTCH2), a putative
tumour suppressor gene inbasal cell carcinoma and
medulloblastoma on chromosome 1p32. Hum Mol Genet
1999;8:291–297.
7. Pastorino L, Ghiorzo P, Nasti S, et al. Identification of a SUFU
germline mutation in a family with Gorlin syndrome. Am J
Med Genet A. 2009;149A:1539–1543.
8. Hottinger AF, Khakoo Y. Neurooncology of familial cancer
syndromes. J Child. Neurol 2009; 24:1526–1535
9. Plaza M.,Borja MJ, Altman N, Saigal1 G, Conventional and
Advanced MRI Features of Pediatric Intracranial Tumors:
Posterior Fossa and Suprasellar Tumors AJR 2013; 200:1115–
1124.
10. N Rodríguez, F Otayza, E Bravo, A Cáceres, M Gálvez, et al,
Tumores primarios malignos del sistema nervioso central en
pediatria, Tumores en niños, cap 29, p 385-410 CG Rostion
Edición 1 , Mediterráneo 2007.
11. Kameda-Smith MM, White MAJ, St. George EJ, Brown JIM
Time to diagnosis of pediatric posterior fossa tumors: an
11-year West of Scotland experience. 2013. 2000–2011. Br
J Neurosurg 27(3):364–369.
12. Localization of lesions affecting the ocular motor system. In:
Brazis PW, Masdeu JC, Biller J (eds) Localization in clinical
neurology, 3rd edn. Little, Brown and Company (Inc), Boston,
1996, pp 155–250.
13. Bender MB Brain control of conjugate horizontal and vertical
eye movements: a survey of the structural correlates. Brain
1980, 103:23–69.
14. Brainstem and cranial nerves. In: Duus P (ed) Topical diagnosis
in neurology-anatomy, physiology, signs and symptoms.
Thieme Medical Publishers, Inc., New York, 1998, pp 70–163.
15. Ash PR, Keltner JL Neuro-ophthalmologic signs in pontine
lesions. Medicine. 1979. 58(4):304–320.
16. Posterior fossa syndromes. In: Needham CW (ed) Neurosurgical
syndromes of the brain. Charles C Thomas, Springfi eld, 1973,
pp 276–346.
17. Gilman S. Cerebellum and motor
dysfunction.In: Asbury
AK, McKhann GM, McDonald WI (eds) Diseases of the
nervous system. Clinical neurobiology, 2nd edn. Saunders,
Philadelphia, 1992, pp 319–341.
18. Mc Lendon RE, Wistler OD, Kros JM et al. Ependymoma. In:
Louis DN (ed) WHO classification of tumors of the central
nervous system. IARC, Lyon, 2007, pp 74–78.
19. Medicine » Oncology » "Evolution of the Molecular Biology of
Brain Tumors and the Therapeutic Implications", book edited
by Terry Lichtor, ISBN 978-953-51-0989-1, Published:
February 27, 2013 under CC BY 3.0 license. © The Author(s).
Chapter 20, New Molecular Targets and Treatments for
Pediatric Brain Tumors By Claudia C. Faria, Christian A. Smith
and James T. Rutka DOI: 10.5772/5330019.
20. Witt H, Mack SC, Ryzhova M, Bender S, Sill M, Isserlin R, et
al. Delineation of two clinically and molecularly distinct
subgroups of posterior fossa ependymoma. Cancer Cell , 2011,
20(2):143–157.
21. Perilongo G, Massimino M, Sotti G, Belfontali T,Masiero
L, Rigobello L et al. Analyses of prognostic factors in a
retrospective review of 92 children with ependymoma: Italian
pediatric neuro-oncology group. Med Pediatr Oncol, 1997,
29(2):79–85.
22. Horn B, Heideman R, Geyer R, Pollack I, Packer R, Goldwein J
et al. A multi-institutional retrospective study of intracranial
ependymoma in children: identifi cation of risk factors. J
Pediatr Hematol Oncol, 1999, 21(3):203–211.
23. Robertson PL, Zeltzer PM, Boyett JM, Rorke LB, Allen JC, Geyer
JR et al. Survival and prognostic factors following radiation
therapy and chemotherapy for ependymomas in children:
a report of the children’s cancer group. J Neurosurg, 1998,
88(4):695–703.
24. Pejavar S, Polley MY, Rosenberg-Wohl S, Chennupati S, Prados
MD, Berger MS et al. Pediatric intracranial ependymoma: the
roles of surgery, radiation and chemotherapy. J Neurooncol ,
2012,106(2):367–375.
25. Von Hoff K, Kieffer V, Habrand JL, Kalifa C,Dellatolas G, Grill
J. Impairment of intellectual functions after surgery and
posterior fossa irradiation in children with ependymoma is
related to age and neurologic complications. BMC Cancer,
2008, 8:15.
26. Conklin HM, Li C, Xiong X, Ogg RJ, Merchant TE Predicting
change in academic abilities after conformal radiation
therapy for localized ependymoma. J Clin Oncol, 2008,
26(24):3965–3970.
27. Landau E, Boop FA, Conklin HM, Wu S, Xiong X, Merchant TE
Supratentorial ependymoma: disease control, complications,
and functional outcomes after irradiation. Int J Radiat Oncol
Biol Phys, 2013, 85(4):e193–e199.
28. Massimino M, Gandola L, Giangaspero F, Sandri A, Valagussa
P, Perilongo G, et al. AIEOP Pediatric Neuro-Oncology Group.
Hyperfractionated radiotherapy and chemotherapy for
childhood ependymoma: fi nal results of the first prospective
AIEOP (Associazione Italiana di Ematologia- Oncologia
Pediatrica) study. Int J Radiat Oncol Biol Phys, 2004,
58(5):1336–1345.
29. Orkin SH, Fisher DE, Look TA et al (eds). Oncology of infancy and
childhood, 2009, 1st edn. Saunders, Elsevier, Philadelphia.
30. Qaddoumi I, Sultan I, Broniscer A. Pediatric low-grade
gliomas and the need for new options for therapy: why and
how? Cancer Biol Ther, 2009, 8(1):4–10.
31. Adam J. Fleming and Mark W. Kieran Genetics of Cerebellar
Low-Grade Astrocytomas, chapter 25, p431-446, Ozek
et al. (eds.), Posterior Fossa Tumors in Children, 265 DOI
10.1007/978-3-319-11274-9_14, ˝ Springer International
Publishing Switzerland 2015.
[REV. MED. CLIN. CONDES - 2017; 28(3) 378-391]